These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33542466)

  • 1. Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis.
    Parenti S; Rontauroli S; Carretta C; Mallia S; Genovese E; Chiereghin C; Peano C; Tavernari L; Bianchi E; Fantini S; Sartini S; Romano O; Bicciato S; Tagliafico E; Della Porta M; Manfredini R
    NPJ Precis Oncol; 2021 Feb; 5(1):4. PubMed ID: 33542466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective.
    Rontauroli S; Carretta C; Parenti S; Bertesi M; Manfredini R
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
    Pasca S; Chifotides HT; Verstovsek S; Bose P
    Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].
    Yan X; Qin TJ; Li B; Qu SQ; Pan LJ; Li FH; Liu NN; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):276-283. PubMed ID: 37356995
    [No Abstract]   [Full Text] [Related]  

  • 6. Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.
    Beer PA; Delhommeau F; LeCouédic JP; Dawson MA; Chen E; Bareford D; Kusec R; McMullin MF; Harrison CN; Vannucchi AM; Vainchenker W; Green AR
    Blood; 2010 Apr; 115(14):2891-900. PubMed ID: 20008300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.
    Angelini DF; Ottone T; Guerrera G; Lavorgna S; Cittadini M; Buccisano F; De Bardi M; Gargano F; Maurillo L; Divona M; Noguera NI; Consalvo MI; Borsellino G; Bernardi G; Amadori S; Venditti A; Battistini L; Lo-Coco F
    Clin Cancer Res; 2015 Sep; 21(17):3977-85. PubMed ID: 25957287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.
    Seipel K; Graber C; Flückiger L; Bacher U; Pabst T
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia.
    Hayun M; Zaatra M; Itzkovich C; Sahar D; Rosenberg D; Filatova M; Ringelstein-Harlev S; Baris H; Moustafa-Hawash N; Louria-Hayon I; Ofran Y
    Sci Rep; 2020 May; 10(1):8349. PubMed ID: 32433559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated Phase of Myeloproliferative Neoplasms.
    Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
    Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misfolded N-CoR is Linked to the Ectopic Reactivation of CD34/Flt3-Based Stem-Cell Phenotype in Promyelocytic and Monocytic Acute Myeloid Leukemia.
    Nin DS; Li F; Visvanathan S; Khan M
    Front Oncol; 2015; 5():210. PubMed ID: 26500885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Basophilia May Suggest an "Accelerated Phase" in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia.
    Dobrowolski J; Pasca S; Teodorescu P; Selicean C; Rus I; Zdrenghea M; Bojan A; Trifa A; Fetica B; Petrushev B; Rosu AM; Berindan-Neagoe I; Tomuleasa C; Dima D
    Front Oncol; 2019; 9():872. PubMed ID: 31555600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
    Engle EK; Fisher DA; Miller CA; McLellan MD; Fulton RS; Moore DM; Wilson RK; Ley TJ; Oh ST
    Leukemia; 2015 Apr; 29(4):869-76. PubMed ID: 25252869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 (V617F) positive primary myelofibrosis.
    Pierini T; Di Giacomo D; Pierini V; Gorello P; Barba G; Lema Fernandez AG; Pellanera F; Iannotti T; Falzetti F; La Starza R; Mecucci C
    Mol Cytogenet; 2016; 9(1):68. PubMed ID: 27594918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted molecular characterization shows differences between primary and secondary myelofibrosis.
    Courtier F; Garnier S; Carbuccia N; Guille A; Adélaide J; Chaffanet M; Hirsch P; Paz DL; Slama B; Vey N; Ugo V; Delhommeau F; Rey J; Birnbaum D; Murati A
    Genes Chromosomes Cancer; 2020 Jan; 59(1):30-39. PubMed ID: 31340059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic conversion involving
    Gurban P; Mambet C; Botezatu A; Necula LG; Neagu AI; Matei L; Pitica IM; Nedeianu S; Chivu-Economescu M; Bleotu C; Ataman M; Mocanu G; Saguna C; Pavel AG; Stambouli D; Sepulchre E; Anton G; Diaconu CC; Constantinescu SN
    Front Oncol; 2023; 13():1266996. PubMed ID: 37841434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis.
    Brattås MK; Lilleeng K; Hovland R; Lægreid IJ; Vorland M; Leh F; Bruserud Ø; Gjertsen BT; Reikvam H
    Biomark Res; 2018; 6():33. PubMed ID: 30479769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of a primary myelofibrosis with progression and related literature review of progression phase genetics.
    Chen D; Fuda F; Weinberg O
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():78-81. PubMed ID: 34288445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm.
    Rampal R; Mascarenhas J
    Curr Opin Hematol; 2014 Mar; 21(2):65-71. PubMed ID: 24366192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms.
    Calabresi L; Carretta C; Romagnoli S; Rotunno G; Parenti S; Bertesi M; Bartalucci N; Rontauroli S; Chiereghin C; Castellano S; Gentili G; Maccari C; Vanderwert F; Mannelli F; Della Porta M; Manfredini R; Vannucchi AM; Guglielmelli P
    Am J Hematol; 2023 Oct; 98(10):1520-1531. PubMed ID: 37399248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.